Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial

• मुख्य लेखकों: Sanie Sesay (लेखक), Jerzy Brzostek (लेखक), Ingo Meyer (लेखक), Yves Donazzolo (लेखक), Geert Leroux-Roels (लेखक), Régine Rouzier (लेखक), Béatrice Astruc (लेखक), Henryk Szymanski (लेखक), Nicole Toursarkissian (लेखक), Corinne Vandermeulen (लेखक), Edyta Kowalska (लेखक), Pierre Van Damme (लेखक), Camille Salamand (लेखक), Stephanie Pepin (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Taylor & Francis Group, 2018-03-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Here, we report a randomized multicenter phase III trial assessing the lot-to-lot consistency of the 2014-2015 Northern Hemisphere quadrivalent split-virion inactivated influenza vaccine (IIV4; Sanofi Pasteur) and comparing its immunogenicity and safety with that of trivalent inactivated influenza v...